Cti Biopharma reported $125.92M in Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Baxter International BAX:US USD 28.29B 322M
Cti Biopharma CTIC:US USD 125.92M 2.46M
Cytori Therapeutics CYTX:US USD 23.87M 763K
Mirati Therapeutics MRTX:US USD 1.2B 100.44M
Northwest Biotherapeutics NWBO:US USD 31.1M 3.58M
Novartis NOVN:VX USD 117.45B 1.01B
Novartis NVS:US USD 117.45B 1.01B
Seattle Genetics SGEN:US USD 3.67B 55.45M
Teva Pharmaceutical Industries TEVA:US USD 44.01B 246M
YTE INCY:US USD 5.84B 330.77M